These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25502729)

  • 21. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
    Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
    Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
    Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
    J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
    Allen SD; Osin P; Nerurkar A
    Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.
    Mamtani A; Nakhlis F; Downs-Canner S; Zabor EC; Morrow M; King TA; Van Zee KJ
    Ann Surg Oncol; 2019 Dec; 26(13):4264-4271. PubMed ID: 31440931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years.
    Van Zee KJ; Subhedar P; Olcese C; Patil S; Morrow M
    Ann Surg; 2015 Oct; 262(4):623-31. PubMed ID: 26366541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ductal carcinoma in situ of breast: detection and treatment pattern in Hong Kong.
    Yau TK; Chan A; Cheung PS
    Hong Kong Med J; 2017 Feb; 23(1):19-27. PubMed ID: 27779099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death.
    Roses RE; Arun BK; Lari SA; Mittendorf EA; Lucci A; Hunt KK; Kuerer HM
    Ann Surg Oncol; 2011 Oct; 18(10):2873-8. PubMed ID: 21476105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
    Grimm LJ; Ghate SV; Hwang ES; Soo MS
    Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
    Solin LJ; Gray R; Hughes LL; Wood WC; Lowen MA; Badve SS; Baehner FL; Ingle JN; Perez EA; Recht A; Sparano JA; Davidson NE
    J Clin Oncol; 2015 Nov; 33(33):3938-44. PubMed ID: 26371148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction.
    Spiegel AJ; Butler CE
    Plast Reconstr Surg; 2003 Feb; 111(2):706-11. PubMed ID: 12560691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study.
    Castellano I; Marchiò C; Tomatis M; Ponti A; Casella D; Bianchi S; Vezzosi V; Arisio R; Pietribiasi F; Frigerio A; Mano MP; Ricardi U; Allia E; Accortanzo V; Durando A; Bussolati G; Tot T; Sapino A
    Mod Pathol; 2010 Feb; 23(2):260-9. PubMed ID: 19915523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
    Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.
    Muhsen S; Barrio AV; Miller M; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2017 Dec; 24(13):3888-3895. PubMed ID: 28828599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.
    Lopez Gordo S; Blanch Falp J; Lopez-Gordo E; Just Roig E; Encinas Mendez J; Seco Calvo J
    Int J Surg; 2019 Mar; 63():98-106. PubMed ID: 30738200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ.
    Miligy IM; Gorringe KL; Toss MS; Al-Kawaz AA; Simpson P; Diez-Rodriguez M; Nolan CC; Ellis IO; Green AR; Rakha EA
    Mod Pathol; 2018 Dec; 31(12):1807-1815. PubMed ID: 29955142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast.
    Millis RR; Pinder SE; Ryder K; Howitt R; Lakhani SR
    Br J Cancer; 2004 Apr; 90(8):1538-42. PubMed ID: 15083182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
    Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
    Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.